Risk | Moderately High |
---|---|
Min SIP Amount | ₹500 |
Expense Ratio | 0.69% |
NAV | ₹12.52 (20 Jan 2021) |
---|---|
Fund Started | 29 Dec 2019 |
Fund Size | ₹260 Cr |
Name | Sector | Instrument | % Assets |
---|---|---|---|
HDFC Bank Ltd. | Financial | Equity | 4.1% |
Infosys Ltd. | Technology | Equity | 4.0% |
ICICI Bank Ltd. | Financial | Equity | 3.4% |
Reliance Industries Ltd. | Energy | Equity | 3.1% |
Larsen & Toubro Ltd. | Construction | Equity | 2.7% |
Tata Consultancy Services Ltd. | Technology | Equity | 2.7% |
Kotak Mahindra Bank Ltd. | Financial | Equity | 2.7% |
Atul Ltd. | Chemicals | Equity | 2.6% |
Federal Bank Ltd. | Financial | Equity | 2.6% |
Strides Pharma Science Ltd. | Healthcare | Equity | 2.5% |
Mahindra Manulife Top 250 Nivesh Yojana Direct Growth is a Equity Mutual Fund Scheme launched by Mahindra Mutual Fund. This scheme was made available to investors on 29 Dec 2019. V Balasubramanian is the Current Fund Manager of Mahindra Manulife Top 250 Nivesh Yojana Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹260 Cr and the Latest NAV as of 20 Jan 2021 is ₹12.52.
The Mahindra Manulife Top 250 Nivesh Yojana Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 1000. Exit load of 1%, if redeemed within 1 year.
The Scheme seeks long term capital growth through investments in equity and equity related securities of both large cap and mid cap stocks.